Form 8-K - Current report:
SEC Accession No. 0001104659-26-071916
Filing Date
2026-06-09
Accepted
2026-06-09 17:15:22
Documents
13
Period of Report
2026-06-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20260608x8k.htm   iXBRL 8-K 44988
2 EX-10.1 tmb-20260608xex10d1.htm EX-10.1 87693
  Complete submission text file 0001104659-26-071916.txt   260526

Data Files

Seq Description Document Type Size
3 EX-101.SCH tmb-20260608.xsd EX-101.SCH 3332
4 EX-101.DEF tmb-20260608_def.xml EX-101.DEF 2803
5 EX-101.LAB tmb-20260608_lab.xml EX-101.LAB 16544
6 EX-101.PRE tmb-20260608_pre.xml EX-101.PRE 9652
16 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20260608x8k_htm.xml XML 4633
Mailing Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059
Business Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 261077122
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)